TalkMed Group Ltd

1
SGX:5G3 (Singapore)  
S$ 0.37 (0%) Mar 27
14.60
P/B:
5.79
Market Cap:
S$ 484.23M ($ 359.36M)
Enterprise V:
S$ 409.88M ($ 304.18M)
Volume:
-
Avg Vol (2M):
18.62K
Volume:
-
Avg Vol (2M):
18.62K

Business Description

Description
TalkMed Group Ltd operates as an investment holding company. It is a provider of medical oncology, stem cell transplants and palliative care services, serving patients in Singapore and the region. Outside Singapore, the Group operates in Vietnam, Hong Kong and the People's Republic of China. The activities of the company are the provision of medical oncology services and palliative care healthcare services in Singapore. It is organized into three reportable operating segments, Oncology Services, Stem Cells Services and Cellular and gene therapy-related products and services. The company has operational footprints across Singapore, Hong Kong and Vietnam of which Singapore contributes the vast majority of total revenue. It generates maximum revenue from the Oncology services segment.
Name Current Vs Industry Vs History
Cash-To-Debt 11.28
Equity-to-Asset 0.79
Debt-to-Equity 0.09
Debt-to-EBITDA 0.17
Interest Coverage 126.86
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 15.42
Distress
Grey
Safe
Beneish M-Score -2.74
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 43.13
9-Day RSI 43.86
14-Day RSI 44.12
6-1 Month Momentum % -5.06
12-1 Month Momentum % -8.54

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.01
Quick Ratio 3.96
Cash Ratio 3.54
Days Sales Outstanding 42.77

Financials

SGX:5G3's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

TalkMed Group Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil S$) 81.926
EPS (TTM) (S$) 0.025
Beta 0
Volatility % 12.95
14-Day RSI 44.12
14-Day ATR (S$) 0.002783
20-Day SMA (S$) 0.3665
12-1 Month Momentum % -8.54
52-Week Range (S$) 0.36 - 0.44
Shares Outstanding (Mil) 1,326.66

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

TalkMed Group Ltd Filings

Filing Date Document Date Form
No Filing Data

TalkMed Group Ltd Stock Events

Financials Calendars
Event Date Price(S$)
No Event Data

TalkMed Group Ltd Frequently Asked Questions

What is TalkMed Group Ltd(SGX:5G3)'s stock price today?
The current price of SGX:5G3 is S$0.37. The 52 week high of SGX:5G3 is S$0.44 and 52 week low is S$0.36.
When is next earnings date of TalkMed Group Ltd(SGX:5G3)?
The next earnings date of TalkMed Group Ltd(SGX:5G3) is .
Does TalkMed Group Ltd(SGX:5G3) pay dividends? If so, how much?
The  Dividend Yield %  of TalkMed Group Ltd(SGX:5G3) is 6.58% (As of Today), Highest Dividend Payout Ratio of TalkMed Group Ltd(SGX:5G3) was 1.21. The lowest was 0.53. And the median was 0.83. The  Forward Dividend Yield % of TalkMed Group Ltd(SGX:5G3) is 7.12%. For more information regarding to dividend, please check our Dividend Page.

Press Release

Subject Date
No Press Release